SHOULDER INNOVATIONS, INC. Depreciation
SHOULDER INNOVATIONS, INC. (SI) reported Depreciation of $1.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. depreciation for the quarter ending 2026-06-30 was $1.11M, a 72.32% increase year-over-year.
- SHOULDER INNOVATIONS, INC. depreciation for the quarter ending 2026-03-31 was $1.06M, a 78.25% increase year-over-year.
- SHOULDER INNOVATIONS, INC. depreciation for the quarter ending 2025-12-31 was $905.00K, a 66.36% increase year-over-year.
- SHOULDER INNOVATIONS, INC. depreciation for the quarter ending 2025-09-30 was $768.00K, a 57.06% increase year-over-year.
- SHOULDER INNOVATIONS, INC. depreciation for fiscal 2025 was $2.91M, a 53.38% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. depreciation for fiscal 2024 was $1.90M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.11M 10-Q · filed 2026-08-06 | $2.17M 10-Q · filed 2026-08-06 | $3.07M derived: sum of 3 quarters · filed 2026-08-06 | $3.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.06M 10-Q · filed 2026-05-13 | $1.96M derived: sum of 2 quarters · filed 2026-05-13 | $2.73M derived: sum of 3 quarters · filed 2026-05-13 | $3.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $905.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.67M derived: sum of 2 quarters · filed 2026-03-10 | $2.32M derived: sum of 3 quarters · filed 2026-08-06 | $2.91M 10-K · filed 2026-03-10 |
| 2025-09-30 | $768.00K 10-Q · filed 2025-11-12 | $1.41M derived: sum of 2 quarters · filed 2026-08-06 | $2.00M 10-Q · filed 2025-11-12 | $2.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $643.00K 10-Q · filed 2026-08-06 | $1.24M 10-Q · filed 2026-08-06 | $1.78M derived: sum of 3 quarters · filed 2026-08-06 | $2.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $593.00K 10-Q · filed 2026-05-13 | $1.14M derived: sum of 2 quarters · filed 2026-05-13 | $1.63M derived: sum of 3 quarters · filed 2026-05-13 | $2.07M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $544.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.03M derived: sum of 2 quarters · filed 2026-03-10 | $1.47M derived: sum of 3 quarters · filed 2026-03-10 | $1.90M 10-K · filed 2026-03-10 |
| 2024-09-30 | $489.00K 10-Q · filed 2025-11-12 | $929.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.35M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $440.00K 10-Q · filed 2025-09-09 | $863.00K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |